meptazinol has been researched along with scopolamine hydrobromide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ennis, C; Stephens, RJ | 1 |
Broadley, J; Robson, P; Wilson, T | 1 |
Chen, HZ; Cui, Y; Ge, XX; Li, J; Liu, T; Qiu, ZB; Wang, H; Xia, Z; Xie, Q; Xu, J; Xu, JR; Zhang, WW | 1 |
Chen, HZ; Ge, XX; Jiang, P; Le, WD; Lu, Y; Qiu, ZB; Shao, BY; Sun, J; Wang, H; Xia, Z; Xie, Q; Zhang, WW | 1 |
1 trial(s) available for meptazinol and scopolamine hydrobromide
Article | Year |
---|---|
The use of meptazinol as a premedication for surgical patients.
Topics: Adolescent; Adult; Aged; Azepines; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Male; Meptazinol; Middle Aged; Opium; Preanesthetic Medication; Random Allocation; Respiration; Scopolamine; Surgical Procedures, Operative | 1982 |
5 other study(ies) available for meptazinol and scopolamine hydrobromide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A comparison of the effects of meptazinol and morphine on the release of acetylcholine from slices of mouse cerebral cortex.
Topics: Acetylcholine; Animals; Azepines; Cerebral Cortex; Female; Kinetics; Meptazinol; Mice; Morphine; Oxotremorine; Scopolamine; Tetrodotoxin | 1984 |
Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Brain; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Female; Humans; Kinetics; Male; Maze Learning; Memory Disorders; Meptazinol; Mice; Models, Molecular; Nootropic Agents; Scopolamine; Sesquiterpenes | 2013 |
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Drug Administration Schedule; Humans; Maze Learning; Meptazinol; Mice; Mice, Transgenic; Neuroblastoma; Phenylcarbamates; Presenilin-1; RNA, Messenger; Scopolamine | 2014 |